Stem cell agency considers intellectual property
ICOC board members. File photo.
February 10, 2006
SAN FRANCISCO--(BUSINESS WIRE)--On Friday (2/10/06), the
Independent Citizens' Oversight Committee (ICOC) for the California
Institute for Regenerative Medicine (CIRM) will meet at Stanford
The ICOC will consider the Draft CIRM Regulations as recommended
by the Standards Working Group last week in Los Angeles. Under
the proposed regulations, CIRM will be the first agency to:
- legally mandate specialized review by a Stem Cell Research
Oversight (SCRO) committee;
- enhance state and federal policies in the areas of voluntary-informed
- protect health of women donating eggs for research;
- guarantee that all cell lines used by CIRM-funded researchers
are derived without compensation to egg donors.
This draft reaffirms Proposition 71's prohibition of human reproductive
cloning. Once ratified by the ICOC, the regulations will enter
into the formal rule-making process governed by the Administrative
Procedures Act and have the force of California law.
Members of the ICOC will also consider the Intellectual Property
Policy for Non-Profits, as recommended by the IP Task Force last
month. The draft policy surpasses federal statute on the sharing
of data and biomedical materials. It also allows California research
institutions to freely use all CIRM-funded patented inventions.
The policy incorporates input taken from the general public and
the legislature over the past four months. With ICOC's approval,
the terms and conditions of the IP policy for Non-Profits will
also enter into California's formal rule-making process.
The ICOC will hear a presentation, co-sponsored with the Alliance
for Stem Cell Research, on Type I and Type II Diabetes at the
beginning of the meeting. Presenters will include scientists Jeffrey
A. Bluestone, Ph.D. and Michael S. German, M.D., both of the UCSF
Diabetes Center; patients Bernadette Revak and Cole Conroy; national
youth advocate Dana Lewis of the American Diabetes Association;
and Francisco J. Prieto, M.D. of the ICOC.
To see the full agenda for the February 10 meeting, please visit
Independent Citizens' Oversight Committee, the 29-member
governing board of the CIRM.
FRIDAY, FEBRUARY 10
8:30 AM - 5:30 PM (Estimated)
Arrillaga Alumni Center
326 Galvez Street
Stanford, CA 94305
The ICOC is responsible for the oversight and management of the
CIRM, which was established in 2004 with the passage of Proposition
71, the California Stem Cell Research and Cures Initiative. The
statewide ballot measure, which provided $3 billion in funding
for stem cell research at California universities and research
institutions, was approved by California voters, and called for
the establishment of an entity to make grants and provide loans
for stem cell research, research facilities, and other vital research